Vaccine Ordering from Toronto Public Health

High-Risk Client

The following vaccines are available free for eligible high-risk clients:

Hepatitis A Vaccine

• Individuals with chronic liver disease, including hepatitis B and C
• Individuals who use injection drugs
• Men who have sex with men (MSM)

Hepatitis B Vaccine

• Infants born to hepatitis B carrier mothers premature infants weighing < 2000 grams at birth
• Premature infants weighing ≥ 2000 grams at birth and full/post term infants
• Children under seven years of age, whose families have emigrated from countries with a high prevalence of hepatitis B or may be exposed to hepatitis B carriers through their extended families
• Household and sexual contacts of chronic carriers and acute cases
• Individuals with a history of a sexually transmitted infection; multiple sex partners or MSMs
• Individuals with chronic liver disease, including hepatitis C
• Individuals who use injection drugs
• Individuals awaiting liver transplants (Only second and third doses are publicly funded.)
• Individuals with a needle-stick injury, in a non-health care setting
• Individuals on renal dialysis or persons with diseases requiring frequent receipt of blood products, such as haemophilia. (Only second and third doses are publicly funded.)

Meningococcal Conjugated A, C, Y, W Vaccine

Individuals, nine months of age and older with:

• Functional or anatomic asplena
• Complement, properdin, factor D deficiency or primary antibody deficiencies
• Pre/post cochlear implant recipients
• Human immunodeficiency viruses (HIV) or acquired complement deficiency (e.g., receiving eculizumab)
• Menactra®/Menveo® is licensed up to age 55. Men-C-ACYW vaccines are not authorized for use in those 56 years of age and older; however, it is recommended for close contacts or in an outbreak situation.

Multicomponent Meningococcal B (4CMenB) Vaccine

Individuals, two months to 17 years with:

• Functional or anatomic asplenia
• Complement, properdin, factor D or primary antibody deficiencies
• Pre/post Cochlear implant recipients
• HIV or acquired complement deficiencies (e.g., receiving eculizumab)

Human papillomavirus Vaccine

• Individuals, up to 26 years of age who self-identify as MSM (gay, bisexual or trans*).

Order Vaccines for High-Risk Clients

Health care providers that fit the eligibility criteria may order vaccines for high-risk clients through the Online Vaccine Order Form.

Online Vaccine Order Form

Student Immunizations

Students in Toronto are required under Ontario’s Immunization of School Pupils Act (ISPA) to have up-to-date vaccinations or valid exemptions, based on age, for measles, mumps, rubella, diphtheria, tetanus, polio, meningococcal, pertussis (whooping cough), and varicella* (chickenpox). Vaccination schedule is according to Ontario’s Publicly Funded Immunization schedule. Students can be suspended from school if they are not up-to-date with the ISPA.

In addition, students are strongly recommended to receive the hepatitis B and human papillomavirus (HPV) vaccines for free before they leave high school. Students cannot be suspended if they do not receive these two vaccines.

TPH offers hepatitis B, Human Papillomavirus vaccines and meningococcal vaccines to students for free until the end of high school, OR they can receive them from their health care provider if eligible.

There are two methods for ordering vaccines for students in Toronto, depending on the vaccine:

1. To order Measles, Mumps, Rubella, Diphtheria, Tetanus, Polio, Meningococcal, Pertussis (whooping cough), and Varicella* (chickenpox) vaccines: refer to Routine or Other Publicly Funded Vaccines and Supplies
2. To order Hepatitis B, Human Papillomavirus and Meningococcal C-ACWY for students who meet the following eligibility criteria, use the Online Vaccine Order Form.

Online Vaccine Order Form

*only applies to students born on or after 2010

Hepatitis B Vaccine

• Grade 7 to 12 students who have not already received or completed their vaccine series

Human Papillomavirus-9 Vaccine

• Grade 7 to 12 students who have not already received or completed their vaccine series
• Males up to 26 years, who identify as having sex with men

Please include the student’s first and last name, plus their date of birth.

Meningococcal-quadrivalent

Individuals 12 and older who have not received one publicly funded dose of quadrivalent meningococcal vaccine who are:

• Students in grades 7–12
• Individuals born on or after January 1, 1997 who did not get a dose in school or as an adult
• Individual born between 1986 and 1996 who never received a Men C-C or Meningococcal ACYW

REMINDER: Receipt of Vaccines Must be Reported to TPH to Avoid Student Suspension

Students (16 years of age or older) and parents can report, access and upload vaccination records through Report Student Vaccination (ISPA) or call TPH at 416-338-7600 to update vaccination records.

Influenza Vaccine

Universal Influenza Immunization Program

In Ontario, influenza vaccines arrive into the distribution system annually in mid to late September.

Toronto healthcare providers can anticipate the delivery of their auto-shipment from the Ontario Government Pharmaceutical and Medical Supply Service (OGPMSS) starting early October, 2025, based on provider type.

Reordering:

Orders for additional doses can be placed on or after October 20, 2025.

• Toronto healthcare providers, excluding pharmacists, within the M postal code can submit their re-orders directly to OGPMSS by faxing the Influenza Vaccine Order Form to 416-327-0818.
• Call 416-327-0837 or email at ogpmss@supplyontario.ca for questions about vaccine ordering.
• Orders sent BEFORE October 20, 2025, will not be fulfilled and must be re-submitted.

For more information:

• MOH – Universal Influenza Immunization Program

RSV Vaccine

RSV Vaccine Prevention Program

To order RSV products from TPH, health care providers can submit RSV vaccine orders for eligible clients using the updated Toronto Provider RSV Vaccine Order form.

• Send completed forms to vaccineorder@toronto.ca
• Do not submit batch orders.

TPH will be monitoring orders and may contact HCPs for clarification.

Eligibility criteria:

Two different vaccine products are available for adults this year.

RSV Vaccine (Arexvy, Abrysvo™)

• All individuals aged 75 and older (NEW for the 2025-26 season)
• Individuals 60 to 74 years of age who fall under one of the following high-risk categories: 
  • Residents of long-term care homes, Elder Care Lodges, or retirement homes including similar settings (e.g., co-located facilities).
  • Patients in hospital receiving alternate level of care (ALC) including similar settings (e.g., complex continuing care, hospital transitional programs)
  • Patients with glomerulonephritis (GN) who are moderately to severely immunocompromised
  • Patients receiving hemodialysis or peritoneal dialysis
  • Recipients of solid organic or hematopoietic stem cell transplants
  • Individuals experiencing homelessness
  • Individuals who identify as First Nations, Inuit, or Métis
• Pregnant individuals from 32 to 36 weeks gestational age if they will deliver prior to or during RSV season* can be given Abrysvo™, in consultation with their health care provider.
  • If the vaccine (Abrysvo™) is given during pregnancy, the monoclonal antibody (Beyfortus®) is NOT recommended to be given to the infant except under specific circumstances:  
    • Infants born less than 14 days after administration of Abrysvo™ OR  
    • Infants who meet the medical criteria for increased risk of severe RSV disease:
      • All premature infants (i.e., <37 weeks gestation)
      • Infants who meet any of the below high-risk criteria 

If an individual has previously received a dose of RSV vaccine they do not need to receive another dose this season, as booster doses are not currently recommended.

Monoclonal Antibody [Nirsevimab (Beyfortus™)]

• Infants born April 1, 2025, or after and less than 8 months of age up to the end of the RSV season*
• High-risk children up to 24 months of age who remain vulnerable from severe RSV disease through their second RSV season, with:
  • Chronic lung disease (CLD), including bronchopulmonary dysplasia (BPD)/chronic lung disease
    • Note: Children who were less than 12 months of age and approved for coverage in the previous RSV season for CLD and BPD remain eligible, irrespective of their clinical status in the second RSV season.
  • Hemodynamically significant congenital heart disease (CHD)
  • Severe immunodeficiency
  • Down syndrome/Trisomy 21
  • Cystic fibrosis with respiratory involvement and/or growth delay
  • Neuromuscular disease impairing clearing of respiratory secretions
  • Severe congenital airway anomalies impairing the clearing of respiratory secretions

*RSV season is usually from November to April, peaking in December. Infants and high-risk children should receive the RSV product starting October 1^st to provide protection before RSV activity begins.

Beyfortus® 100mg cannot be split to make Beyfortus® 50mg doses.

COVID-19 Vaccine

Routine or Other Publicly Funded Vaccines and Supplies

Toronto health care providers can order routine vaccines, immunization cards and other supplies via Ontario Government Pharmaceutical and Medical Supply Services (OGPMSS). Health care providers use the Ministry form: Requisition for Biological Supplies to order routine vaccines, immunization cards and other supplies. Then fax directly to OGPMSS.

For questions about your vaccine order, contact:
OGPMSS Customer Service
99 Adesso Drive,1st floor. Concord, ON L4K 3C7
Tel: 416-327-0837
Fax: 416-327-0818
Email: OGPMSS.moh@ontario.ca

For more information, see Publicly Funded Immunization Schedule for Ontario.